{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:41:56Z","timestamp":1792219316115,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12020-016-1133-0","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:49:12Z","timestamp":1476146952000},"page":"885-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Chiara","family":"Diazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Brigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Zirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"issue":"2","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11102-008-0092-8","volume":"12","author":"TL Stanley","year":"2009","unstructured":"T.L. Stanley, S.K. Grinspoon, GH\/GHRH axis in HIV lipodystrophy. Pituitary 12(2), 143\u2013152 (2009). doi: 10.1007\/s11102-008-0092-8","journal-title":"Pituitary"},{"issue":"6","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/01.aids.0000218549.85081.8f","volume":"20","author":"P Koutkia","year":"2006","unstructured":"P. Koutkia, K. Eaton, S.M. You, J. Breu, S. Grinspoon, Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution. AIDS 20(6), 855\u2013862 (2006). doi: 10.1097\/01.aids.0000218549.85081.8f","journal-title":"AIDS"},{"issue":"1","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1210\/jc.2004-1342","volume":"90","author":"P Koutkia","year":"2005","unstructured":"P. Koutkia, B. Canavan, J. Breu, S. Grinspoon, Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy. J. Clin. Endocrinol. Metab. 90(1), 32\u201338 (2005). doi: 10.1210\/jc.2004-1342","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2265.2009.03603.x","volume":"71","author":"J Lo","year":"2009","unstructured":"J. Lo, S.M. You, J. Wei, B. Canavan, S. Grinspoon, Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults. Clin. Endocrinol. 71(6), 815\u2013822 (2009). doi: 10.1111\/j.1365-2265.2009.03603.x","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/eje-11-0829","volume":"166","author":"L Zirilli","year":"2012","unstructured":"L. Zirilli, G. Orlando, F. Carli, B. Madeo, S. Cocchi, C. Diazzi, C. Carani, G. Guaraldi, V. Rochira, GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls. Eur. J. Endocrinol. 166(3), 415\u2013424 (2012). doi: 10.1530\/eje-11-0829","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1530\/eje-13-0961","volume":"170","author":"G Brigante","year":"2014","unstructured":"G. Brigante, C. Diazzi, A. Ansaloni, L. Zirilli, G. Orlando, G. Guaraldi, V. Rochira, Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution. Eur. J. Endocrinol. 170(5), 685\u2013696 (2014). doi: 10.1530\/eje-13-0961","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/jci2908","volume":"102","author":"CA Jaffe","year":"1998","unstructured":"C.A. Jaffe, B. Ocampo-Lim, W. Guo, K. Krueger, I. Sugahara, R. DeMott-Friberg, M. Bermann, A.L. Barkan, Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J. Clin. Invest. 102(1), 153\u2013164 (1998). doi: 10.1172\/jci2908","journal-title":"J. Clin. Invest."},{"issue":"10","key":"1133_CR8","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2003-030246","volume":"88","author":"SK Jessup","year":"2003","unstructured":"S.K. Jessup, E.V. Dimaraki, K.V. Symons, A.L. Barkan, Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men. J. Clin. Endocrinol. Metab. 88(10), 4776\u20134780 (2003). doi: 10.1210\/jc.2003-030246","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1210\/jcem-42-5-942","volume":"42","author":"E Wiedemann","year":"1976","unstructured":"E. Wiedemann, E. Schwartz, A.G. Frantz, Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man. J. Clin. Endocrinol. Metab. 42(5), 942\u2013952 (1976). doi: 10.1210\/jcem-42-5-942","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1133_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1490117","volume":"149","author":"F Cordido","year":"2003","unstructured":"F. Cordido, P. Alvarez-Castro, M.L. Isidro, F.F. Casanueva, C. Dieguez, Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur. J. Endocrinol. 149(2), 117\u2013122 (2003)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/eje.1.01967","volume":"153","author":"G Corneli","year":"2005","unstructured":"G. Corneli, C. Di Somma, R. Baldelli, S. Rovere, V. Gasco, C.G. Croce, S. Grottoli, M. Maccario, A. Colao, G. Lombardi, E. Ghigo, F. Camanni, G. Aimaretti, The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur. J. Endocrinol. 153(2), 257\u2013264 (2005). doi: 10.1530\/eje.1.01967","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1133_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-0495(96)90288-7","volume":"45","author":"M Maccario","year":"1996","unstructured":"M. Maccario, M. Procopio, S. Grottoli, S.E. Oleandri, G.M. Boffano, M. Taliano, F. Camanni, E. Ghigo, Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism 45(3), 342\u2013346 (1996)","journal-title":"Metabolism"},{"issue":"3","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrendo.2010.199","volume":"7","author":"CG Fiorenza","year":"2011","unstructured":"C.G. Fiorenza, S.H. Chou, C.S. Mantzoros, Lipodystrophy: pathophysiology and advances in treatment. Nat. Rev. Endocrinol. 7(3), 137\u2013150 (2011). doi: 10.1038\/nrendo.2010.199","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/jcem.86.2.7175","volume":"86","author":"P Rietschel","year":"2001","unstructured":"P. Rietschel, C. Hadigan, C. Corcoran, T. Stanley, G. Neubauer, J. Gertner, S. Grinspoon, Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J. Clin. Endocrinol. Metab. 86(2), 504\u2013510 (2001). doi: 10.1210\/jcem.86.2.7175","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9571","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/s0140-6736(07)60673-4","volume":"369","author":"HJ Schneider","year":"2007","unstructured":"H.J. Schneider, G. Aimaretti, I. Kreitschmann-Andermahr, G.K. Stalla, E. Ghigo, Hypopituitarism. Lancet 369(9571), 1461\u20131470 (2007). doi: 10.1016\/s0140-6736(07)60673-4","journal-title":"Lancet"},{"issue":"6","key":"1133_CR16","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1210\/jc.2012-4012","volume":"98","author":"S Melmed","year":"2013","unstructured":"S. Melmed, Idiopathic adult growth hormone deficiency. J. Clin. Endocrinol. Metab. 98(6), 2187\u20132197 (2013). doi: 10.1210\/jc.2012-4012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrendo.2013.64","volume":"9","author":"DE Berryman","year":"2013","unstructured":"D.E. Berryman, C.A. Glad, E.O. List, G. Johannsson, The GH\/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat. Rev. Endocrinol. 9(6), 346\u2013356 (2013). doi: 10.1038\/nrendo.2013.64","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9 Suppl","key":"1133_CR18","first-page":"33","volume":"31","author":"L Zirilli","year":"2008","unstructured":"L. Zirilli, G. Orlando, C. Diazzi, N. Squillace, C. Carani, G. Guaraldi, V. Rochira, Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? J. Endocrinol. Invest. 31(9 Suppl), 33\u201338 (2008)","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"1133_CR19","doi-asserted-by":"publisher","first-page":"E296","DOI":"10.1152\/ajpendo.00335.2003","volume":"286","author":"P Koutkia","year":"2004","unstructured":"P. Koutkia, G. Meininger, B. Canavan, J. Breu, S. Grinspoon, Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 286(2), E296\u2013303 (2004). doi: 10.1152\/ajpendo.00335.2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"1133_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"M.E. Molitch, D.R. Clemmons, S. Malozowski, G.R. Merriam, M.L. Vance, Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(6), 1587\u20131609 (2011). doi: 10.1210\/jc.2011-0179","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"1133_CR21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"K.A. Lichtenstein, D.J. Ward, A.C. Moorman, K.M. Delaney, B. Young, F.J. Palella Jr., P.H. Rhodes, K.C. Wood, S.D. Holmberg, Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15(11), 1389\u20131398 (2001)","journal-title":"AIDS"},{"issue":"3","key":"1133_CR22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1530\/eje.0.1340352","volume":"134","author":"E Ghigo","year":"1996","unstructured":"E. Ghigo, G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Camanni, New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 134(3), 352\u2013356 (1996)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"1133_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1210\/jcem.83.5.4837","volume":"83","author":"G Aimaretti","year":"1998","unstructured":"G. Aimaretti, G. Corneli, P. Razzore, S. Bellone, C. Baffoni, E. Arvat, F. Camanni, E. Ghigo, Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J. Clin. Endocrinol. Metab. 83(5), 1615\u20131618 (1998). doi: 10.1210\/jcem.83.5.4837","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/cen.12839","volume":"83","author":"M Losa","year":"2015","unstructured":"M. Losa, P. Beck-Peccoz, G. Aimaretti, C. Di Somma, M.R. Ambrosio, D. Ferone, A. Giampietro, S.M. Corsello, M. Poggi, C. Scaroni, N. Jia, G. Mossetto, S. Cannavo, V. Rochira, Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry. Clin. Endocrinol. 83(4), 527\u2013535 (2015). doi: 10.1111\/cen.12839","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"1133_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03345381","volume":"28","author":"G Aimaretti","year":"2005","unstructured":"G. Aimaretti, G. Corneli, C. Di Somma, R. Baldelli, V. Gasco, S. Rovere, G. Migliaretti, A. Colao, G. Tamburrano, G. Lombardi, E. Ghigo, F. Camanni, Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease. J. Endocrinol. Invest. 28(3), 247\u2013252 (2005)","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"1133_CR26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03345359","volume":"28","author":"R Baldelli","year":"2005","unstructured":"R. Baldelli, A. Bianchi, F. Diacono, M. Passeri, A. Fusco, D. Valle, M. Poggi, M. Terlini, V. Toscano, G. Tamburrano, A. Pontecorvi, G. Maira, L. De Marinis, Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas. J. Endocrinol. Invest. 28(2), 157\u2013161 (2005)","journal-title":"J. Endocrinol. Invest."},{"issue":"9 Suppl","key":"1133_CR27","first-page":"6","volume":"31","author":"F Prodam","year":"2008","unstructured":"F. Prodam, L. Pagano, G. Corneli, G. Golisano, S. Belcastro, A. Busti, V. Gasco, G. Beccuti, S. Grottoli, C. Di Somma, A. Colao, E. Ghigo, G. Aimaretti, Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency. J. Endocrinol. Invest. 31(9 Suppl), 6\u201311 (2008)","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"1133_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/eje-07-0631","volume":"157","author":"KK Ho","year":"2007","unstructured":"K.K. Ho, Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European society for pediatric endocrinology, Lawson Wilkins society, European society of endocrinology, Japan endocrine society, and endocrine society of Australia. Eur. J. Endocrinol. 157(6), 695\u2013700 (2007). doi: 10.1530\/eje-07-0631","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"1133_CR29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/sj.ijo.0801982","volume":"26","author":"YW Park","year":"2002","unstructured":"Y.W. Park, S.B. Heymsfield, D. Gallagher, Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int. J. Obes. Relat. Metab. Disord. 26(7), 978\u2013983 (2002). doi: 10.1038\/sj.ijo.0801982","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"3","key":"1133_CR30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/j.1550-8528.1999.tb00404.x","volume":"7","author":"JL Clasey","year":"1999","unstructured":"J.L. Clasey, C. Bouchard, C.D. Teates, J.E. Riblett, M.O. Thorner, M.L. Hartman, A. Weltman, The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes. Res. 7(3), 256\u2013264 (1999)","journal-title":"Obes. Res."},{"issue":"4","key":"1133_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1994.tb02583.x","volume":"41","author":"AA Toogood","year":"1994","unstructured":"A.A. Toogood, C.G. Beardwell, S.M. Shalet, The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin. Endocrinol. 41(4), 511\u2013516 (1994)","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1133_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"M.L. Hartman, B.J. Crowe, B.M. Biller, K.K. Ho, D.R. Clemmons, J.J. Chipman, Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?. J. Clin. Endocrinol. Metab. 87(2), 477\u2013485 (2002). doi: 10.1210\/jcem.87.2.8216","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1133_CR33","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1210\/jc.2003-030761","volume":"89","author":"RD Murray","year":"2004","unstructured":"R.D. Murray, J.E. Adams, S.M. Shalet, Adults with partial growth hormone deficiency have an adverse body composition. J. Clin. Endocrinol. Metab. 89(4), 1586\u20131591 (2004). doi: 10.1210\/jc.2003-030761","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1133_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2265.2009.03754.x","volume":"73","author":"RD Murray","year":"2010","unstructured":"R.D. Murray, G. Wieringa, J.A. Lawrance, J.E. Adams, S.M. Shalet, Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness. Clin. Endocrinol. 73(4), 508\u2013515 (2010). doi: 10.1111\/j.1365-2265.2009.03754.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"1133_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2265.2010.03809.x","volume":"73","author":"SM Shalet","year":"2010","unstructured":"S.M. Shalet, Partial growth hormone deficiency in adults; should we be looking for it?. Clin. Endocrinol. 73(4), 432\u2013435 (2010). doi: 10.1111\/j.1365-2265.2010.03809.x","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"1133_CR36","doi-asserted-by":"publisher","first-page":"e28512","DOI":"10.1371\/journal.pone.0028512","volume":"6","author":"V Rochira","year":"2011","unstructured":"V. Rochira, L. Zirilli, G. Orlando, D. Santi, G. Brigante, C. Diazzi, F. Carli, C. Carani, G. Guaraldi, Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS ONE 6(12), e28512 (2011). doi: 10.1371\/journal.pone.0028512","journal-title":"PLoS ONE"},{"issue":"3","key":"1133_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ecl.2014.06.005","volume":"43","author":"V Rochira","year":"2014","unstructured":"V. Rochira, G. Guaraldi, Hypogonadism in the HIV-infected man. Endocrinol. Metab. Clin. North Am. 43(3), 709\u2013730 (2014). doi: 10.1016\/j.ecl.2014.06.005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"1133_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/eje-11-0558","volume":"166","author":"A Hazem","year":"2012","unstructured":"A. Hazem, M.B. Elamin, I. Bancos, G. Malaga, G. Prutsky, J.P. Domecq, T.A. Elraiyah, N.O. Abu Elnour, Y. Prevost, J.P. Almandoz, C. Zeballos-Palacios, E.R. Velasquez, P.J. Erwin, N. Natt, V.M. Montori, M.H. Murad, Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. Eur. J. Endocrinol. 166(1), 13\u201320 (2012). doi: 10.1530\/eje-11-0558","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"1133_CR39","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/eje-12-0002","volume":"166","author":"CJ Gardner","year":"2012","unstructured":"C.J. Gardner, A.J. Irwin, C. Daousi, I.A. McFarlane, F. Joseph, J.D. Bell, E.L. Thomas, V.L. Adams, G.J. Kemp, D.J. Cuthbertson, Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study. Eur. J. Endocrinol. 166(6), 993\u20131002 (2012). doi: 10.1530\/eje-12-0002","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"1133_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/eje-10-0702","volume":"164","author":"A Egger","year":"2011","unstructured":"A. Egger, T. Buehler, C. Boesch, P. Diem, C. Stettler, E.R. Christ, The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study. Eur. J. Endocrinol. 164(1), 23\u201329 (2011). doi: 10.1530\/eje-10-0702","journal-title":"Eur. J. Endocrinol."},{"key":"1133_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/b978-0-444-59602-4.00028-9","volume":"124","author":"EM Erfurth","year":"2014","unstructured":"E.M. Erfurth, Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: growth hormone deficiency. Handb. Clin. Neurol. 124, 407\u2013416 (2014). doi: 10.1016\/b978-0-444-59602-4.00028-9","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"1133_CR42","first-page":"1","volume":"38","author":"L Audi","year":"2013","unstructured":"L. Audi, M. Fernandez-Cancio, N. Camats, A. Carrascosa, Growth hormone deficiency: an update. Minerva. Endocrinol. 38(1), 1\u201316 (2013)","journal-title":"Minerva. Endocrinol."},{"issue":"7","key":"1133_CR43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/gerona\/glt168","volume":"69","author":"S Pathai","year":"2014","unstructured":"S. Pathai, H. Bajillan, A.L. Landay, K.P. High, Is HIV a model of accelerated or accentuated aging? J. Gerontol. A. Biol. Sci. Med. Sci. 69(7), 833\u2013842 (2014). doi: 10.1093\/gerona\/glt168","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"issue":"2","key":"1133_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/coh.0000000000000240","volume":"11","author":"V Appay","year":"2016","unstructured":"V. Appay, A.D. Kelleher, Immune activation and immune aging in HIV infection. Curr. Opin. HIV AIDS 11(2), 242\u2013249 (2016). doi: 10.1097\/coh.0000000000000240","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"2","key":"1133_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/andr.310","volume":"3","author":"V Rochira","year":"2015","unstructured":"V. Rochira, C. Diazzi, D. Santi, G. Brigante, A. Ansaloni, M.C. Decaroli, S. De Vincentis, C. Stentarelli, S. Zona, G. Guaraldi, Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology 3(2), 298\u2013308 (2015). doi: 10.1111\/andr.310","journal-title":"Andrology"},{"issue":"3","key":"1133_CR46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00198-015-3383-8","volume":"27","author":"D Santi","year":"2016","unstructured":"D. Santi, B. Madeo, F. Carli, S. Zona, G. Brigante, F. Vescini, G. Guaraldi, V. Rochira, Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study. Osteoporos. Int. 27(3), 1103\u20131114 (2016). doi: 10.1007\/s00198-015-3383-8","journal-title":"Osteoporos. Int."},{"issue":"17","key":"1133_CR47","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"T.T. Brown, R.B. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20(17), 2165\u20132174 (2006). doi: 10.1097\/QAD.0b013e32801022eb","journal-title":"AIDS"},{"issue":"2","key":"1133_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0956462413492714","volume":"25","author":"CE Short","year":"2014","unstructured":"C.E. Short, S.G. Shaw, M.J. Fisher, K. Walker-Bone, Y.C. Gilleece, Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK. Int. J. STD AIDS 25(2), 113\u2013121 (2014). doi: 10.1177\/0956462413492714","journal-title":"Int. J. STD AIDS"},{"issue":"10","key":"1133_CR49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/hiv.12162","volume":"15","author":"K Petoumenos","year":"2014","unstructured":"K. Petoumenos, P. Reiss, L. Ryom, M. Rickenbach, C.A. Sabin, W. El-Sadr, A. d\u2019Arminio Monforte, A.N. Phillips, S. De Wit, O. Kirk, F. Dabis, C. Pradier, J.D. Lundgren, M.G. Law, Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV. Med. 15(10), 595\u2013603 (2014). doi: 10.1111\/hiv.12162","journal-title":"HIV. Med."},{"issue":"10","key":"1133_CR50","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4330\/wjc.v7.i10.633","volume":"7","author":"S Shahbaz","year":"2015","unstructured":"S. Shahbaz, M. Manicardi, G. Guaraldi, P. Raggi, Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J. Cardiol. 7(10), 633\u2013644 (2015). doi: 10.4330\/wjc.v7.i10.633","journal-title":"World J. Cardiol."},{"issue":"23","key":"1133_CR51","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1056\/NEJMoa072375","volume":"357","author":"J Falutz","year":"2007","unstructured":"J. Falutz, S. Allas, K. Blot, D. Potvin, D. Kotler, M. Somero, D. Berger, S. Brown, G. Richmond, J. Fessel, R. Turner, S. Grinspoon, Metabolic effects of a growth hormone-releasing factor in patients with HIV. N. Eng. J. Med. 357(23), 2359\u20132370 (2007). doi: 10.1056\/NEJMoa072375","journal-title":"N. Eng. J. Med."},{"issue":"12","key":"1133_CR52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","volume":"19","author":"J Falutz","year":"2005","unstructured":"J. Falutz, S. Allas, D. Kotler, M. Thompson, P. Koutkia, J. Albu, B. Trottier, J.P. Routy, P. Cote, T. Abribat, S. Grinspoon, A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation. AIDS 19(12), 1279\u20131287 (2005)","journal-title":"AIDS"},{"issue":"14","key":"1133_CR53","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/QAD.0b013e32830a5058","volume":"22","author":"J Falutz","year":"2008","unstructured":"J. Falutz, S. Allas, J.C. Mamputu, D. Potvin, D. Kotler, M. Somero, D. Berger, S. Brown, G. Richmond, J. Fessel, R. Turner, S. Grinspoon, Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. AIDS 22(14), 1719\u20131728 (2008). doi: 10.1097\/QAD.0b013e32830a5058","journal-title":"AIDS"},{"issue":"9","key":"1133_CR54","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1210\/jc.2010-0490","volume":"95","author":"J Falutz","year":"2010","unstructured":"J. Falutz, J.C. Mamputu, D. Potvin, G. Moyle, G. Soulban, H. Loughrey, C. Marsolais, R. Turner, S. Grinspoon, Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J. Clin. Endocrinol. Metab. 95(9), 4291\u20134304 (2010). doi: 10.1210\/jc.2010-0490","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1133_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/QAI.0b013e3181cbdaff","volume":"53","author":"J Falutz","year":"2010","unstructured":"J. Falutz, D. Potvin, J.C. Mamputu, H. Assaad, M. Zoltowska, S.E. Michaud, D. Berger, M. Somero, G. Moyle, S. Brown, C. Martorell, R. Turner, S. Grinspoon, Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. J. Acquir. Immune. Defic. Syndr. 53(3), 311\u2013322 (2010). doi: 10.1097\/QAI.0b013e3181cbdaff","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"issue":"10","key":"1133_CR56","doi-asserted-by":"publisher","first-page":"e0140358","DOI":"10.1371\/journal.pone.0140358","volume":"10","author":"A Mangili","year":"2015","unstructured":"A. Mangili, J. Falutz, J.C. Mamputu, M. Stepanians, B. Hayward, Predictors of treatment response to tesamorelin, a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat. PLoS. ONE. 10(10), e0140358 (2015). doi: 10.1371\/journal.pone.0140358","journal-title":"PLoS. ONE."},{"issue":"2","key":"1133_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ecl.2012.04.014","volume":"41","author":"SJ Weroha","year":"2012","unstructured":"S.J. Weroha, P. Haluska, The insulin-like growth factor system in cancer. Endocrinol. Metab. Clin. North. Am. 41(2), 335\u2013350 (2012). doi: 10.1016\/j.ecl.2012.04.014 . vi","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"1133_CR58","doi-asserted-by":"publisher","unstructured":"L.S. Park, J.P. Tate, K. Sigel, D. Rimland, K. Crothers, C. Gibert, M.C. Rodriguez-Barradas, M.B. Goetz, R.J. Bedimo, S.T. Brown, A.C. Justice, R. Dubrow, Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997\u20132012. AIDS 30(11), 1795\u2013806 (2016). doi: 10.1097\/qad.0000000000001112","DOI":"10.1097\/qad.0000000000001112"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1133-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:48:21Z","timestamp":1498337301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1133-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1133-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]}}}